v3.24.1.1.u2
Segment Information - Schedule of Company Revenue and Adjusted EBITDA by Segment (Details) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Segment Revenue          
Recognized revenue     $ 219,638,000 $ 299,489,000 $ 271,893,000
Segment Adjusted EBITDA          
Total Adjusted EBITDA     (175,796,000) (161,301,000) (150,740,000)
Adjustments          
Net loss     (666,704,000) (311,656,000) (217,490,000)
Interest income, net     (14,331,000) (9,676,000) (277,000)
Other (income) expense, net     (506,000) 93,000 83,000
Changes in fair value of warrant liabilities     0 0 (32,989,000)
Provision for (benefit from) income taxes     73,000 (2,772,000) (3,480,000)
Depreciation and amortization     18,033,000 20,239,000 18,899,000
Amortization of acquired intangible assets     11,448,000 16,486,000 7,269,000
Impairment of acquired intangible assets     0 9,968,000 0
Stock-based compensation expense     120,209,000 116,017,000 57,933,000
Acquisition-related costs     0 0 9,362,000
Litigation settlement, net     98,000 0 9,950,000
Loss on disposition and transaction-related costs     2,375,000 0 0
Goodwill impairment $ 152,900,000 $ 198,800,000 351,744,000 0 0
Cybersecurity incident expenses, net of probable insurance recoveries     1,765,000 0 0
Total Adjusted EBITDA     (175,796,000) (161,301,000) (150,740,000)
Corporate, Non-Segment          
Segment Adjusted EBITDA          
Total Adjusted EBITDA     (48,002,000) (54,801,000) (43,684,000)
Consumer and Research Services          
Segment Revenue          
Recognized revenue     219,638,000 299,489,000 271,893,000
Consumer and Research Services | Operating Segments          
Segment Adjusted EBITDA          
Total Adjusted EBITDA     (36,769,000) (17,997,000) (30,112,000)
Therapeutics          
Segment Revenue          
Recognized revenue     0 0 0
Therapeutics | Operating Segments          
Segment Adjusted EBITDA          
Total Adjusted EBITDA     $ (91,025,000) $ (88,503,000) $ (76,944,000)